SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001554795-14-000300
Filing Date
2014-04-17
Accepted
2014-04-17 08:41:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 gnbt0416form424b3.htm 424B3 5262627
  Complete submission text file 0001554795-14-000300.txt   5263624
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0314
Type: 424B3 | Act: 33 | File No.: 333-195057 | Film No.: 14768788
SIC: 2834 Pharmaceutical Preparations